Browsing Tag
Dupilumab
2 posts
Dupilumab Shows Benefits in Larger EoE Cohort
PHOENIX — New results from a separate, larger phase 3 trial confirm the benefits of dupilumab (Dupixent) in adults and adolescents with eosinophilic esophagitis (EoE), showing that weekly injections of the biologic sent 59% of EoE patients into disease remission after 24 weeks. The late-breaking data on Part B of the LIBERTY EoE TREET study…
Dupilumab Effective for Up To 1 Year in Teens With AD: Study
Serious adverse events remained rare and skin remained largely clear in adolescents treated with dupilumab (Dupixent) for moderate-to-severe atopic dermatitis (AD) for up to 52 weeks in a phase 3 open-label extension trial, researchers reported. At 1 year, 86% of 50 remaining patients with weights under 60 kg (132 lb) had achieved 75% improvement (EASI-75;…